Therapeutic efficacy of immunotherapy for gastric cancer metastasis

被引：0

作者：

Xie, Fei-Fei ^{[1
]}

Qian, Su-Ting ^{[1
]}

Zhao, Hao-Yu ^{[1
]}

Liu, Qing-Sheng ^{[2
]}

机构：

[1] Zhejiang Chinese Med Univ, Hangzhou Hosp Tradit Chinese Med, Dept Digest, Hangzhou 310007, Zhejiang, Peoples R China

[2] Zhejiang Chinese Med Univ, Hangzhou Hosp Tradit Chinese Med, Sci & Educ Sect, 453 Stadium Rd, Hangzhou 310007, Zhejiang, Peoples R China

来源：

WORLD JOURNAL OF GASTROINTESTINAL SURGERY | 2024年 / 16卷 / 12期

关键词：

Gastric cancer; Metastasis; Immunotherapy; Liver metastasis; Lung metastasis; Peritoneal metastasis; GASTROESOPHAGEAL JUNCTION; PLUS CHEMOTHERAPY; PD-L1; EXPRESSION; INHIBITORS;

D O I：

10.4240/wjgs.v16.i12.3881

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Gastric cancer (GC) metastasis is the main cause of poor prognosis for GC patients. In recent years, breakthroughs in immunotherapy have been made in the treatment of many kinds of cancers, providing new hope for patients with GC metastasis. This paper reviews the mechanism of immunotherapy in GC metastasis and its clinical application, and discusses and compares the research and efficacy of immunotherapy in patients with liver metastasis, lung metastasis, peritoneal metastasis and lymph node metastasis of GC. This study explores the challenges and future development directions of immunotherapy, and provides a theoretical basis and clinical guidance for the precise treatment of patients with GC metastasis.

引用

页数：7